[HTML][HTML] Breaking therapy resistance: an update on oncolytic newcastle disease virus for improvements of cancer therapy
V Schirrmacher, S van Gool, W Stuecker - Biomedicines, 2019 - mdpi.com
Resistance to therapy is a major obstacle to cancer treatment. It may exist from the
beginning, or it may develop during therapy. The review focusses on oncolytic Newcastle …
beginning, or it may develop during therapy. The review focusses on oncolytic Newcastle …
[HTML][HTML] Oncolytic viruses for triple negative breast cancer and beyond
S Jin, Q Wang, H Wu, D Pang, S Xu - Biomarker Research, 2021 - Springer
Biological therapy is considered an alternative treatment capable of eliciting the same
effects on tumors as surgery, radiotherapy, and chemotherapy. As a major player in …
effects on tumors as surgery, radiotherapy, and chemotherapy. As a major player in …
[HTML][HTML] Development of molecular mechanisms and their application on oncolytic Newcastle disease virus in cancer therapy
F Huang, C Dai, Y Zhang, Y Zhao, Y Wang… - Frontiers in Molecular …, 2022 - frontiersin.org
Cancer is caused by the destruction or mutation of cellular genetic materials induced by
environmental or genetic factors. It is defined by uncontrolled cell proliferation and …
environmental or genetic factors. It is defined by uncontrolled cell proliferation and …
[HTML][HTML] Inhibition of tumor growth and metastasis by Newcastle disease virus strain P05 in a breast cancer mouse model
OA Ortega-Rivera, P Gallegos-Alcalá… - Journal of Breast …, 2023 - ncbi.nlm.nih.gov
Purpose Conventional therapies and surgery remain the standard treatment for breast
cancer. However, combating the eventual development of metastasis is still a challenge …
cancer. However, combating the eventual development of metastasis is still a challenge …
Current advances in microbial-based cancer therapies
Microbes have an immense metabolic capability and can adapt to a wide variety of
environments; as a result, they share complicated relationships with cancer. The goal of …
environments; as a result, they share complicated relationships with cancer. The goal of …
[HTML][HTML] Molecular cytogenomic characterization of the murine breast cancer cell lines C-127I, EMT6/P and TA3 Hauschka
S Azawi, T Liehr, M Rincic, M Manferrari - International journal of …, 2020 - mdpi.com
Background: To test and introduce effective and less toxic breast cancer (BC) treatment
strategies, animal models, including murine BC cell lines, are considered as perfect …
strategies, animal models, including murine BC cell lines, are considered as perfect …
[HTML][HTML] The role of the tumor microenvironment in developing successful therapeutic and secondary prophylactic breast cancer vaccines
Breast cancer affects roughly one in eight women over their lifetime and is a leading cause
of cancer-related death in women. While outcomes have improved in recent years …
of cancer-related death in women. While outcomes have improved in recent years …
[HTML][HTML] Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus
Z Huang, M Liu, Y Huang - Discovery medicine, 2020 - discoverymedicine.com
Newcastle disease virus (NDV) replicates in the cytoplasm and disintegrates the host
genome or participates in recombination, and has a strong affinity for tumor cells. These …
genome or participates in recombination, and has a strong affinity for tumor cells. These …
[HTML][HTML] The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer
D Sánchez, G Cesarman-Maus, L Romero… - Viruses, 2024 - mdpi.com
The absence of tumor-infiltrating lymphocytes negatively impacts the response to
chemotherapy and prognosis in all subtypes of breast cancer. Therapies that stimulate a …
chemotherapy and prognosis in all subtypes of breast cancer. Therapies that stimulate a …
[HTML][HTML] Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
SUFS Najmuddin, ZM Amin, SW Tan, SK Yeap… - Cancer Cell …, 2020 - Springer
Background Oncolytic viruses have emerged as an alternative therapeutic modality for
cancer as they can replicate specifically in tumour cells and induce toxic effects leading to …
cancer as they can replicate specifically in tumour cells and induce toxic effects leading to …